Friday, February 12, 2016

Appeasing Iran, Then Shortchanging Israel

Middle East: President Obama got friends of Israel in Congress to support his Iran nuclear deal by pledging he would compensate the Jewish state with military aid. It’s another broken promise.
The Israeli DEBKAfile news site reports that Israeli officials meeting with the Obama administration’s National Security Council at the White House were denied a request for additional $1.9 billion in military aid to counter new and enhanced threats. The threats include the increased arms Iran will be able to give the Hezbollah terrorist group with the tens of billions of dollars Tehran will have available from the nuclear deal’s lifting of sanctions.
“The U.S. officials explained that, because of cutbacks in U.S. defense spending, it would not be possible to add a single dollar to Israel’s regular $3.1 billion appropriation,” the Israeli site reported. “After notifying Prime Minister Binyamin Netanyahu and Defense Minister Moshe Ya’alon of this refusal, the Israeli delegation was advised to reduce its application to $900 million. This too was refused.”
It’s so bad that Netanyahu has told Cabinet members, “perhaps we will not manage to come to an agreement with this administration and will need to come to an agreement with the next administration.”
Do we even have to read between the lines to discern that President Obama is such a bad president for the defense of Israel, Bibi has concluded it’s better to wait for the unknown next president, whoever it is — dove Democrats like Hillary Clinton or Bernie Sanders, or even a Republican whose commitment to Israel is, all in all, a mystery.
With Mideast Arab nations receiving advanced weaponry from Russia and China, and the emergence of the bloodthirsty Islamic State caliphate, an Iran teeming with new cash to fund terrorism and strengthen its regional military power is only one of Israel’s new challenges.
Read the rest of this IBD editorial HERE.

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.

No comments: